Gardner’s Respiratory Virus (GRV) is an enveloped, single-stranded RNA (ssRNA) virus that has been shown to cause both upper and lower respiratory tract infections. This virus is an intracellular virus capable of replicating free within the cytoplasm of host cells. Spread through small, airborne viral droplets, GRV invades the physical barrier that is the mucosal surface lining the lungs and respiratory tract. The cells that line this surface are mostly epithelial cells, and GRV enters these cells by being transported across their membranes through receptor mediated endocytosis. Once inside the host cell, GRV replicates and begins its cytopathic effects on the host cells; the infected epithelial cells undergo structural changes that lead to irritation, inflammation, and eventual lysis that can weaken these mucosal surfaces, making the host more susceptible to further pathogenic attack. As with similar viruses, once the first line of defense is breached and GRV is transported into the host cells, the immune response, involving both the innate and adaptive branches of the immune system is initiated and attempts to remove the virus as well as prevent future infection. GRV however, is highly evolved and possesses various evasion mechanisms that prevent the immune system from accomplishing its job; luckily, a drug does exist to help eliminate the virus.
Expected Immune Response The innate immune response is meant to prevent further invasion and replication of the pathogen
Respiratory Syncytial Virus (RSV) causes acute respiratory tract infection in patients of all ages and is one of the most popular diseases of childhood. Respiratory syncytial virus (RSV) infection, which manifests primarily as bronchiolitis and/or viral pneumonia, is the leading cause of lower respiratory tract (LRT) infection in infants and young children. RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lungs) and pneumonia in children under one year of age in the United States. During the first year of life, most infants are infected with the virus. Most RSV infected children encounter
The innate immune system is effective to a certain degree. That said, if the environment is regulated then the body is less likely to get ill. Innate immunity is effective as once the patient matures his immune system will mature due to the B and T memory cells. The memory cells will help the body prepare for the virus once it has arrived. The memory cells will send specialised lymph nodes to the invading pathogen. The B and T memory cells are key to immunity of a virus.
Respiratory Synctial Virus (RSV) is an infection that is contagious that resembles the common cold a lot of times. RSV is the most common viral pathogen that causes lower respiratory tract infections in infants. RSV infection in infancy cause severe bronchiolitis and pneumonia and may incline children to the following development of asthma, the most common chronic illness of childhood. RSV is the most single related cause of pneumonia and bronchiolitis. Epidemics of the virus are seen each winter, 80% of infections typically occur during a three-month period. The virus is not typically severe during infancy but it is rare if it happens. (As, in my case I was born with the RSV virus and was hospitalized for eighteen days and was put on assisted ventilation.) In infants RSV infection can spread to the bronchial tubes and lungs. The virus can also infect adults, in where the infection can cause viral pneumonia, which is sometimes followed by a bacterial infection of the lower respiratory system.
The respiratory syncytial pathogen is a non-segmented negative -sense single stranded RNA virus that falls under the paramyxoviridae family. The virus is comprised of 10 genes the encode 11 proteins and is divided into two subtypes A and B, which further divide into multiple genotypes. Genetic studies have tried
RSV enters a cell through fusion at the plasma membrane. Initiation emerges when the G protein of the RSV binds to a specific long unbranched polysaccharide of the
The body’s protection against viruses, bacteria and other types of invasions is our immune system (Tortora, 2014).
The innate and adaptive immune response start with exposure to an antigen in the epithelium of
Innate Immune System – Nonspecific and abrupt first response; comprised of epithelial surfaces (physical barriers), neutrophils, and macrophages.
understood that the pathogens adapted to the immune system and were immune to its defenses so
Based on research and observation, we now know that infectious diseases are caused by microorganisms (pathogens) and that the immune system provides defense against infectious diseases.
This article covers the Seneca Valley Virus (SVV-001) as a hopeful for an oncolytic treatment of certain cancer types. More specifically those with neuroendocrine properties such as rhabdomyosarcoma, Wilms tumor, glioblastoma, neuroblastoma, and adult small-cell lung cancer. Each of which effect smooth/skeletal muscle cells, kidneys/adrenal glands (mainly in children), astrocytes of the brain, nerve cells of a fetus, and lung cells in adults respectively. The virus was discovered by accident in a contaminated cell culture that contained bovine serum to promote growth. The virus was later discovered to be almost exclusively found in farm animals such as cows and pigs, due to the presence of neutralizing antibodies that were later to only ever have been found in one human sample. Just as important as that, the virus only targets the cells of the above-mentioned cancers/tumors, is a self-replicating RNA virus, and its inability to infect other cells in the body all come together to result in the lysis of these specific cancer cells. These properties alone give great hope for SVV-001 as a treatment for those infected by these diseases, and prompted for more research into its medicinal possibilities.
Human beings are born with immunity as well as they acquire it from the environment they grow in. Human innate immunity is assigned the task to hinder the harmful substances from entering the body. These immunity barriers develop a defense line. The innate immunity includes cough, tear enzymes, mucus, skin and the stomach acid. Hence, the role of innate immune system is to stop harmful materials from entering our body. In case the innate immunity is insufficient to fight, there is acquired immunity that fights harmful substances by getting exposed to various antigens. The acquired immunity is developed against specific antigen. Its role is to fight
Innate immunity refers to antigen-nonspecific defence mechanisms that a host uses immediately or within several hours after exposure to an antigen. This is the immunity that you are born with, and is the initial response by the body to eliminate
If a pathogen breaches barriers: innate immune response result into an immediate effect of non- specific response. All Innate immune systems derived from plants and animals, when a pathogen evades the innate response, a third layer of protection is possessed by vertebrates in which activation of adaptive immune system takes place. The immune system response adopts itself within an infection and pathogen recognition is improved. As a result of the improved response, its then retains itself when the pathogen is eliminated in form of an immunological memory and allows the adaptive immune system to mount faster and stronger when pathogen is encountered each time.
Our immune system is the second most complex system in our body. It is made up of organs, cells and proteins that work together to protect our bodies from harmful bacteria, viruses or other microorganisms that can cause diseases. Usually we don’t notice our immune system defending us against pathogens, but if the pathogen (harmful microorganism) is aggressive or if our body hasn’t ever come into contact with it, we can get sick. The jobs of our immune system are to recognise pathogens, as well as neutralise and remove them from our body. Our immune system also has to fight our own cells if they have changed due to an illness, for example, cancer. (1)